How to Register a Medical Device in Egypt: The Complete 2026 Guide

Egypt is the second-largest medical device market in the Middle East and North Africa: about USD 4.24 billion in devices and USD 440 million in IVD (2023 figures). Domestic manufacturing capacity is limited, so the market depends heavily on imports — a serious opportunity for international manufacturers. A new public-procurement channel has also opened: foreign manufacturers can register with Egypt's Unified Procurement Authority (UPA) system to compete in public tenders.

But Egypt is not an “apply and get approved in weeks” country. Registration runs through the central regulator — the Egyptian Drug Authority (EDA) — on its online MeDevice platform, with class-based assessment, committee reviews, and strict incomplete-dossier discipline. The good news: since early 2025 the EDA has taken major modernization steps — a fast-track route, reliance on reference-market approvals, full migration to the digital MeDevice platform (November 2025), and simplification and tiered-fee measures announced in February 2026.

The regulator: EDA (Egyptian Drug Authority)

The Egyptian Drug Authority (EDA) is the sole competent regulator for medical devices and in vitro diagnostics (IVDs) in Egypt. Within the EDA, the device side is run by the General Administration of Medical Devices (GAMD) — also cited in some sources as the Central Administration of Medical Devices. Pre-market registration, technical assessment, classification, and post-market surveillance all run through this administration.

The core legal framework: Law No. 151 of 2019 designates the EDA as the competent authority for the regulation of medicines and medical devices — the most-cited legal basis for device registration. The older Egyptian Medical Device Law No. 10 of 2003 sets the general regulatory framework for devices; some practitioner sources cite it as the basis of the registration obligation. On the guidance side, EDREX GL.CAMD.002 Version 2 — the EDA's medical device registration guideline — took effect on 1 September 2025 and introduced new steps and tests in dossier quality assessment.

All registration-related transactions run through the EDA's mandatory electronic portal MeDevice (medevice.edaegypt.gov.eg): technical dossier submission, device classification screening, import approvals, annual import plans, and customs pre-clearances. As of November 2025 the EDA fully eliminated paper or hybrid applications for critical operations (import approval, annual plans, customs) — everything is digital.

Classification: the EU model (Class I / IIa / IIb / III)

Egypt has no classification scheme of its own. The EDA references the EU Medical Device Regulation (EU MDR 2017/745); GHTF/IMDRF risk-classification principles are also used:

If the reference market is outside the EU (e.g., the US), the EDA follows that market's classification scheme — but if the device sits in a higher risk class in another acceptable market, the EDA may take the higher-risk approval as the reference and apply stricter scrutiny.

IVDs follow the same risk-based principles but are regulated separately; some sources note an EU IVDR-like A–D classification for IVDs, though no uniform source could be found — confirm with the EDA before filing.

Local representation is mandatory: ERH / MAH

Foreign manufacturers not established in Egypt cannot apply directly. They must appoint a local representative:

• Egyptian Registration Holder (ERH) — also cited as Marketing Authorization Holder (MAH). The ERH can be an EDA-licensed Scientific Office or a duly licensed commercial distributor.

The ERH's duties include preparing the technical dossier and submitting it to the EDA via MeDevice, running all communication between the manufacturer and the EDA, holding the EDA registration on the manufacturer's behalf (the registration certificate is issued in the ERH's name), keeping registration records, reporting incidents and withdrawals, and ensuring compliance across the product lifecycle. The ERH is also the importer of the registered devices — import can only happen through the ERH.

Critical practical consequence: changing the ERH means reprinting all product labels, because the ERH's name appears on the label. ERH selection is therefore a strategic decision — choose a representative with an active EDA relationship and command of the February 2026 simplification measures.

Reliance and fast-track: the biggest accelerators

The Egyptian system leverages existing approvals in recognized reference markets (EU, US, Japan, Australia, Canada) through reliance. This is a major advantage, especially for devices with a CE mark or FDA clearance.

Since early 2025, an accelerated registration route has been open for CE-marked or FDA-cleared devices — particularly for devices with critical intended uses. Per official timings relayed from the EDA: normal route — dossier acceptance/notification in 5 business days, dossier assessment in 20 business days; fast track — acceptance/notification in 3 business days, assessment in 7 business days. Practitioner reports indicate that for single-use devices on fast track, acceptance notification can arrive in 3–4 days with total review completing in 3–4 months.

The EDA's 2025–2026 modernization timeline:

• 25 June 2025: flexible dossier-matching rules (faster registration facilitations with ISO 13485:2016, EU MDR, or GMP certificates)
• 1 September 2025: guideline EDREX GL.CAMD.002 Version 2 in force
• November 2025: full migration to the digital MeDevice platform — paper/hybrid applications closed
• February 2026: simplification measures and tiered fee arrangements announced

Step-by-step registration process

Preparation steps before filing:

• Clarify device classification. Use the AI-assisted classification tool on the MeDevice portal; seek pre-consultation with the EDA for borderline cases.
• Appoint the ERH. Sign a written representation agreement (Letter of Authorization) with an EDA-licensed Scientific Office or licensed distributor.
• Set your reference-market approval strategy. If you hold a CE mark or FDA clearance, assess fast-track eligibility; otherwise plan the FSC plus strong technical-dossier route.

Normal route (full dossier) — for all classes:

• The ERH submits the application via the MeDevice platform.
• Within 5 business days on the normal route (3 on fast track), the EDA notifies whether the dossier is accepted, states the grounds for non-acceptance, or suspends it until deficiencies are completed.
• Dossier assessment: 20 business days normal, 7 business days fast track. At the end of assessment the EDA notifies missing/required documents by email.
• The company is given 60 business days (via MeDevice) to complete deficiencies.
• The EDA performs the final dossier revision; if the dossier is accepted, a Registration License is issued and the company receives a permanent acceptance number.

Special route: non-sterile devices with an incomplete dossier. Where the full registration dossier for a non-sterile device is not yet ready, a parallel route exists:

• The ERH submits the initial (preliminary) registration dossier, including copies of the certificates filed with the General Administration. This permits import for circulation.
• The EDA issues the applicant a temporary acceptance number.
• After the temporary number, import approval is issued through the Registration Department.
• The applicant has 18 months from the acceptance date of the initial dossier; the dossier's core documents must be completed within the first 6 months.
• After the final acceptance number is issued, the company is granted a 1-year import permit until registration procedures are completed.

Document checklist

The EDA is converging on IMDRF-aligned dossier formats (CSDT — Common Submission Dossier Template — or clearly mapped EU MDR/US FDA-based dossiers). A typical dossier includes:

Timelines

In short: the official MeDevice timings look fast, but in practice the total project runs 4–12 months depending on class, dossier completeness, and whether additional committee review is needed. Sterile and high-risk devices take longer; for non-sterile devices, import approval can be obtained before registration completes.

Fees

Source A (practitioner, EGP): Class I 10,000–15,000 EGP; Class II 20,000–40,000 EGP; Class III 50,000+ EGP; IVD case-by-case; subject to ministerial decrees.

Source B (EDA tariff schedule, USD): imported medical device dossier assessment/review — USD 59 normal route, USD 258 fast track. Under the bundling system for non-sterile device groups: 2–10 devices USD 139 normal / 437 fast; 11–20 devices 179/477; 21–30 devices 219/516; 31–40 devices 258/556; 41–50 devices 298/596.

The gap between the two sets likely reflects different fee items (assessment fee vs. total registration fee). Figures may also have changed under the tiered-fee arrangements announced in February 2026 — take the current tariff from MeDevice before paying.

Labeling, language, and UDI

• Language: all labels, packaging, and instructions for use must be in Arabic + English. In practice, Arabic-dominant labeling is accepted for home-use products and English-dominant for professional-use products — clarify with the ERH before submission.
• ERH details: the ERH's name appears on the label; changing the ERH requires reprinting labels.
• UDI: Unique Device Identification compliance is required where applicable.
• Importer record: label information must be consistent with the importer details in the MeDevice record.

Post-registration obligations

Import and customs: only registered devices may be imported. Importers must be EDA-licensed and named in the registration dossier; the registration certificate is mandatory for customs clearance and distribution. For non-sterile devices, import approval can be obtained with the temporary acceptance number before registration completes; for sterile/high-risk devices, expect registration to be completed first.

Post-market surveillance (PMS): the EDA now requires a mandatory Post-Market Surveillance Plan covering complaint handling, adverse-event reporting within 10–30 days depending on severity, and Periodic Safety Update Reports (PSUR).

Public procurement (UPA): foreign manufacturers can register with Egypt's Unified Procurement Authority system to participate in public tenders — an additional revenue channel alongside private-market distribution.

Renewal

Common mistakes and how to avoid them

FAQ

Can a medical device be imported into Egypt without registration? No — unregistered devices cannot be imported or distributed. Exception: early import approval with the temporary acceptance number for non-sterile devices.

Can a foreign manufacturer apply directly? No. Manufacturers not established in Egypt must appoint an ERH (Scientific Office or licensed distributor); the registration certificate is issued in the ERH's name.

Is ISO 13485 mandatory? Yes — an ISO 13485:2016 certificate is required from all applicants (for the US route, a CFG documenting 21 CFR Part 820 compliance is accepted). The EDA does not perform its own QMS audit.

Is a CE mark alone sufficient? No — a CE mark accelerates the process (fast track) but does not replace EDA registration. An EDA registration license is required to market in Egypt.

How long does registration take? Official MeDevice timings are fast (acceptance 3–5 business days, assessment 7–20 business days), but total time in practice is 4–12 months. High-risk committee review adds 2–3 months.

How long is the registration certificate valid? Sources conflict between 5 years and 10 years — verify with the EDA before filing.

What language must labels be in? Arabic + English. Arabic-dominant labeling may be accepted for home-use products, English-dominant for professional-use — clarify with the ERH.

Is there mutual recognition between Egypt and Türkiye? Not yet — harmonization talks surfaced in 2025; no agreement is in force.

Sources: DDReg Pharma (updated 2026-09-07), RegDesk regulations library and EDA simplification briefing, Freyr Solutions, MedEnvoy Global, OMC Medical, Operon Strategist.

Planning Egypt entry for your device? A GHMAP strategy session maps your classification hypothesis, ERH options, fast-track eligibility, and the realistic sequence before you commit budget — book at ghmap.io/pricing.